QA: Diamedica Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001401040_2019_Diamedica_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}

Graph

Absolute values for 0001401040, Diamedica Therapeutics Inc

  xvar xval
0 AssetsCurrent 17,972,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 96,000
3 remainder_Assets 271,000
4 LiabilitiesCurrent 1,296,000
5 LiabilitiesNoncurrent 18,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,739,000
9 ResearchAndDevelopmentExpense 4,522,000
10 remainder_Expenses 80,000
11 remainder_Revenues 500,000
12 remainder_NetIncome 1,107,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 18,339,000
1 Liabilities 1,314,000
2 Expenses 7,341,000
3 Revenues 500,000
4 StockholdersEquity 17,025,000
5 NetIncome -5,734,000
6 ComprehensiveNetIncome -5,734,000
7 BaseVar 14,300,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.19
9 EconomicCapitalRatio 3.82

Edgar->Model Mapping

Feature Distribution